United Therapeutics Corporation Capital Reinvestment Ratio
United Therapeutics Corporation capital reinvestment ratio. United Therapeutics Corporation (UTHR) has a Capital Reinvestment Ratio of 0.34x as of June 2026, meaning it reinvests 0% of its operating cash flow ($313.60 Million) in capital expenditures ($108.00 Million). Check UTHR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of United Therapeutics Corporation (2004–2025)
Capital reinvestment ratio of United Therapeutics Corporation from 2004 to 2025. This chart tracks United Therapeutics Corporation's Capital Reinvestment Ratio across 20 annual periods. Also explore United Therapeutics Corporation annual equity growth to track the company's year-over-year net asset growth rate.
United Therapeutics Corporation Capital Reinvestment Ratio by Year (2004–2025)
United Therapeutics Corporation capital reinvestment ratio by year from 2004 to 2025. For the full cash flow conversion analysis, see United Therapeutics Corporation (UTHR) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | $1.56 Billion | $520.50 Million | ▲ +79.5% |
| 2024 | 0.19x | $1.33 Billion | $246.50 Million | ▼ -21.2% |
| 2023 | 0.24x | $978.00 Million | $230.40 Million | ▲ +36.2% |
| 2022 | 0.17x | $802.50 Million | $138.80 Million | ▼ -14.4% |
| 2021 | 0.20x | $598.20 Million | $120.80 Million | ▲ +157.3% |
| 2020 | 0.08x | $755.70 Million | $59.30 Million | ▼ -66.9% |
| 2018 | 0.24x | $778.40 Million | $184.40 Million | ▲ +30.2% |
| 2017 | 0.18x | $474.20 Million | $86.30 Million | ▲ +171.1% |
| 2016 | 0.07x | $643.60 Million | $43.20 Million | ▼ -48.4% |
| 2015 | 0.13x | $382.80 Million | $49.79 Million | ▼ -2.6% |
| 2014 | 0.13x | $355.30 Million | $47.44 Million | ▲ +77.9% |
| 2013 | 0.08x | $425.27 Million | $31.91 Million | ▼ -78.3% |
| 2012 | 0.35x | $323.63 Million | $111.91 Million | ▲ +140.5% |
| 2011 | 0.14x | $250.19 Million | $35.98 Million | ▲ +63.2% |
| 2010 | 0.09x | $211.53 Million | $18.64 Million | ▼ -90.8% |
| 2009 | 0.96x | $99.72 Million | $95.40 Million | ▲ +21.1% |
| 2007 | 0.79x | $48.95 Million | $38.66 Million | ▲ +149.5% |
| 2006 | 0.32x | $49.39 Million | $15.63 Million | ▲ +123.4% |
| 2005 | 0.14x | $43.17 Million | $6.12 Million | ▼ -43.6% |
| 2004 | 0.25x | $20.78 Million | $5.22 Million | — |